Cargando…

SARS-CoV-2 and EBV coinfection()

Detalles Bibliográficos
Autores principales:	García-Martínez, Francisco Javier, Moreno-Artero, Ester, Jahnke, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486856/ https://www.ncbi.nlm.nih.gov/pubmed/32953993 http://dx.doi.org/10.1016/j.medcle.2020.06.010

Ejemplares similares

Coinfección por SARS-CoV-2 y virus Epstein-Barr
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
por: Roncati, Luca, et al.
Publicado: (2020)

Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022)

Neisseria meningitidis bacteraemia and SARS-CoV-2 infection: a coinfection that reminds previous epidemic outbreaks
por: Martín-Romero, Miguel, et al.
Publicado: (2022)

Rates of Coinfection Between SARS-CoV-2 and Other Respiratory Viruses in Korea
por: Kim, Young-gon, et al.
Publicado: (2022)

Nonpharmaceutical intervention is an effective measure to block respiratory virus coinfections with SARS-CoV-2
por: Ru, Xuanwen, et al.
Publicado: (2023)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

SARS-CoV-2 and dengue virus coinfection involving the skin of an Argentinian female
por: Rosso, Maria V., et al.
Publicado: (2021)

False positives in SARS-CoV-2 disease()
por: Pardo-Lledias, Javier, et al.
Publicado: (2021)

Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?
por: Lugito, Nata Pratama Hardjo
Publicado: (2021)

Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency
por: Toledano-Revenga, Javier, et al.
Publicado: (2023)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Response to “Emphysematous cholecystitis in suspected SARS-CoV-2 infection”()
por: Gómez Sánchez, Javier, et al.
Publicado: (2021)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()
por: Gimeno Castillo, Javier, et al.
Publicado: (2021)

Research during the SARS-CoV-2 pandemic()
por: Muñoz de Nova, José Luis, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Acute necro-hemorrhagic pancreatitis during SARS-CoV-2 infection()
por: Arche Banzo, María José, et al.
Publicado: (2022)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

Prediction of pulmonary embolism in patients with SARS-CoV-2 infection
por: Franco-Moreno, Anabel, et al.
Publicado: (2023)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
por: Crespo, Javier, et al.
Publicado: (2021)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Respiratory Coinfections in Children With SARS-CoV-2
por: Westbrook, Adrianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rr47jrh0256520oulkg25veibf